|[June 12, 2014]
Research and Markets: Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H1 2014
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/hw23pr/coronary_artery)
has announced the addition of the "Coronary
Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H1 2014"
report to their offering.
This report provides comprehensive information on the therapeutic
development for Coronary Artery Disease (CAD) (Ischemic Heart Disease),
complete with comparative analysis at various stages, therapeutics
assessment by drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type, along with latest updates, and
featured news and press releases.
It also reviews key players involved in the therapeutic development for
Coronary Artery Disease (CAD) (Ischemic Heart Disease) and special
features on late-stage and discontinued projects.
Drug profiles/recors featured in the report undergoes periodic updation
following a stringent set of processes that ensures that all the
profiles are updated with the latest set of information. Additionally,
processes including live news & deals tracking, browser based alert-box
and clinical trials registries tracking ensure that the most recent
developments are captured on a real time basis.
The report enhances decision making capabilities and help to create
effective counter strategies to gain competitive advantage. It
strengthens R&D pipelines by identifying new targets and MOAs to produce
first-in-class and best-in-class products.
Reasons to buy
Provides strategically significant competitor information, analysis,
and insights to formulate effective R&D development strategies
Identify emerging players with potentially strong product portfolio
and create effective counter-strategies to gain competitive advantage
Develop strategic initiatives by understanding the focus areas of
Identify and understand important and diverse types of therapeutics
under development for Coronary Artery Disease (CAD) (Ischemic Heart
Bristol-Myers Squibb Company
Daiichi Sankyo Company
Merck & Co
Multi Gene Vascular Systems
For more information visit http://www.researchandmarkets.com/research/hw23pr/coronary_artery
[ Back To TMCnet.com's Homepage ]